Search / Trial NCT06616519

A Study to Evaluate the Safety and Efficacy of MSENC1 Soft Hydrophilic Contact Lenses and Oxypure Color Soft Hydrophilic Contact Lenses

Launched by BENQ MATERIALS CORPORATION · Sep 25, 2024

Trial Information

Current as of October 08, 2024

Completed

Keywords

Description

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Age ≥ 18 years old, no gender limitation;
  • 2. Soft hydrophilic contact lenses worn should be from 0.00D to -12.00D;
  • 3. Subjects should have normal binocular conditions without any abnormality or diseases except for ametropia;
  • 4. The optimal binocular CVA with glasses ≥ 1.0;
  • 5. The astigmatism should be ≤1.5D;
  • 6. Binoculus BUT \>5s;
  • 7. should accept follow-ups for at least 90 days and wear the contact lens as required in the protocol;
  • 8. should understand the purpose of the trial, volunteer to attend and sign the Informed Consent Form by the subjects themselves or their legal guardians.
  • .
  • Exclusion Criteria:
  • 1. Patients who suffer from systemic diseases that prohibit contact lens use or receive treatment that may affect the vision or contact lens use;
  • 2. Patients who have worn hard contact lenses within 4 weeks or soft contact lenses within 7 days before being included in the trial;
  • 3. Patients who are allergic to contact lenses or suffer from systemic allergy;
  • 4. Patients who have keratoconus or other cornea irregularity;
  • 5. Patients who always stay at places that are dry, dust-heavy, having volatile chemicals or otherwise affect the use of soft hydrophilic contact lenses;
  • 6. People who are pregnant, during their lactation or prepare for the pregnancy while being included;
  • 7. People who have only a single eye qualified for the trial;
  • 8. People who have attended a clinical trial of medicine or medical devices other than contact lens within 3 months before being included in this trial;
  • 9. People who have attended a clinical trial of medicine or medical devices other than contact lens within 3 months before being included in this trial;
  • 10. Other cases where investigators determine the soft contact lens should not be used or the candidate should be excluded.

About Benq Materials Corporation

BenQ Materials Corporation is a leading technology firm specializing in advanced materials and innovative solutions for various industries, including electronics, healthcare, and renewable energy. With a strong commitment to research and development, BenQ Materials is dedicated to enhancing product performance and sustainability through cutting-edge technologies. The company actively engages in clinical trials to evaluate and validate the efficacy of its novel materials and applications in medical settings, aiming to contribute to improved patient outcomes and the advancement of healthcare solutions. With a focus on quality, safety, and regulatory compliance, BenQ Materials Corporation strives to leverage its expertise to drive innovation in the clinical research landscape.

Locations

Taoyuan, , China

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0